21190982

Source:http://linkedlifedata.com/resource/pubmed/id/21190982

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0030705, umls-concept:C0040145, umls-concept:C0206530, umls-concept:C0242793, umls-concept:C0521425, umls-concept:C0543431, umls-concept:C0694890, umls-concept:C1096776, umls-concept:C1514474
pubmed:issue	3
pubmed:dateCreated	2011-3-7
pubmed:abstractText	In hereditary medullary thyroid carcinoma (HMTC), prophylactic surgery is the only curative option, which should be properly defined both in time and extent.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0375362
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Calcitonin, http://linkedlifedata.com/resource/pubmed/chemical/DNA, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-ret
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	1945-7197
pubmed:author	pubmed-author:BaudinEE, pubmed-author:Borson-ChazotFF, pubmed-author:BourdelotAA, pubmed-author:CarolRR, pubmed-author:ChabreOO, pubmed-author:ChabrierGG, pubmed-author:Groupe Français des Tumeurs Endocrines, pubmed-author:MuratAA, pubmed-author:NiccoliPP, pubmed-author:RodiekSS, pubmed-author:RohmerVV, pubmed-author:SchlumbergerMM, pubmed-author:SchvartzCC, pubmed-author:TabarinAA, pubmed-author:Vidal-TrecanGG, pubmed-author:WemeauJ LJL
pubmed:issnType	Electronic
pubmed:volume	96
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	E509-18
pubmed:meshHeading	pubmed-meshheading:21190982-Adolescent, pubmed-meshheading:21190982-Adult, pubmed-meshheading:21190982-Calcitonin, pubmed-meshheading:21190982-Carcinoma, Medullary, pubmed-meshheading:21190982-Child, pubmed-meshheading:21190982-Child, Preschool, pubmed-meshheading:21190982-DNA, pubmed-meshheading:21190982-Disease-Free Survival, pubmed-meshheading:21190982-Female, pubmed-meshheading:21190982-Genotype, pubmed-meshheading:21190982-Guidelines as Topic, pubmed-meshheading:21190982-Humans, pubmed-meshheading:21190982-Infant, pubmed-meshheading:21190982-Longitudinal Studies, pubmed-meshheading:21190982-Male, pubmed-meshheading:21190982-Micronucleus, Germline, pubmed-meshheading:21190982-Multiple Endocrine Neoplasia Type 2a, pubmed-meshheading:21190982-Mutation, pubmed-meshheading:21190982-Prognosis, pubmed-meshheading:21190982-Proto-Oncogene Proteins c-ret, pubmed-meshheading:21190982-Retrospective Studies, pubmed-meshheading:21190982-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:21190982-Risk Assessment, pubmed-meshheading:21190982-Thyroid Neoplasms, pubmed-meshheading:21190982-Thyroidectomy, pubmed-meshheading:21190982-Treatment Outcome, pubmed-meshheading:21190982-Young Adult
pubmed:year	2011
pubmed:articleTitle	Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the Groupe Francais d'Etude des Tumeurs Endocrines.
pubmed:affiliation	Centre hospitalier universitaire Angers, Endocrinologie, Faculté de médecine, Université Angers, Angers 49933, France. virohmer@chu-angers.fr
pubmed:publicationType	Journal Article, Multicenter Study